These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 11527113

  • 21. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].
    Fornaro G, Lazzero M, Giacalone A, Aralda D, Prando MD, Rossi L, Bongo AS.
    G Ital Cardiol (Rome); 2008 Jun; 9(6):408-20. PubMed ID: 18681392
    [Abstract] [Full Text] [Related]

  • 22. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group.
    Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143
    [Abstract] [Full Text] [Related]

  • 23. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.
    Am J Cardiol; 2008 Dec 01; 102(11):1427-32. PubMed ID: 19026290
    [Abstract] [Full Text] [Related]

  • 24. Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction.
    Antioch KM, Jennings G, Botti M, Chapman R, Wulfsohn V.
    Eur J Health Econ; 2002 Dec 01; 3(1):26-39. PubMed ID: 15609115
    [Abstract] [Full Text] [Related]

  • 25. [Beta blockers in arrhythmias].
    Fuhrer J.
    Praxis (Bern 1994); 1995 Mar 14; 84(11):304-12. PubMed ID: 7724946
    [Abstract] [Full Text] [Related]

  • 26. Invasive strategy for treatment of myocardial infarction.
    Höfling B, von Pölnitz A.
    J Cardiovasc Pharmacol; 1990 Mar 14; 16 Suppl 5():S120-2. PubMed ID: 11527114
    [Abstract] [Full Text] [Related]

  • 27. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U, Messer C, Stammwitz E, The GS, Dietl J, Bischoff KO, Schulten-Baumer U, Tebbenjohanns J, Gohlke H, Bramlage P, SAMI Studiengruppe.
    Dtsch Med Wochenschr; 2007 Jul 30; 132(30):1559-66. PubMed ID: 17628839
    [Abstract] [Full Text] [Related]

  • 28. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D.
    Acta Med Croatica; 2004 Jul 30; 58(2):129-34. PubMed ID: 15208798
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW, Madhavan SS, Amonkar MM.
    Clin Ther; 2005 May 30; 27(5):630-45. PubMed ID: 15978313
    [Abstract] [Full Text] [Related]

  • 32. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Greenland P, Rosenberg Y, O'Rourke R, Shah PK, Smith S.
    Am Heart J; 2008 Mar 30; 155(3):455-64. PubMed ID: 18294477
    [Abstract] [Full Text] [Related]

  • 33. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ, Heaton PC, Cluxton RJ.
    Ann Pharmacother; 2004 Feb 30; 38(2):286-93. PubMed ID: 14742768
    [Abstract] [Full Text] [Related]

  • 34. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?
    Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KA, GRACE Investigators.
    Circulation; 2007 Dec 11; 116(24):2793-801. PubMed ID: 18025530
    [Abstract] [Full Text] [Related]

  • 35. Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction.
    Arntz HR, Wenzel V, Dissmann R, Marschalk A, Breckwoldt J, Müller D.
    Resuscitation; 2008 Feb 11; 76(2):180-4. PubMed ID: 17728040
    [Abstract] [Full Text] [Related]

  • 36. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
    Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, Hoffman BS, Allen LaPointe N, Peterson E.
    Am Heart J; 2006 Sep 11; 152(3):454.e1-8. PubMed ID: 16923412
    [Abstract] [Full Text] [Related]

  • 37. Practical considerations of beta-blockade in the management of the post-myocardial infarction patient.
    Fonarow GC.
    Am Heart J; 2005 Jun 11; 149(6):984-93. PubMed ID: 15976779
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA, Al Suwaidi J, Bener A, Khinji A, Al Binali HA.
    Int J Cardiol; 2005 Jul 10; 102(2):249-54. PubMed ID: 15982492
    [Abstract] [Full Text] [Related]

  • 40. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ, Frison L, Weaver D, Wilcox RG, Bylock A, Emanuelsson H, Held P, Oldgren J.
    Am Heart J; 2008 Feb 10; 155(2):382-7. PubMed ID: 18215612
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.